Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Plos One|May 12, 2011
Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodiesAmy E Gilbert, Panagiotis Karagiannis, Tihomir Dodev, et al.The Lancet. Oncology|April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 studyPippa G Corrie, Andrea Marshall, Janet A Dunn, et al.Journal of Medicinal Chemistry|July 10, 2010
Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulatorSimon E Ward, Mark Harries, Laura Aldegheri, et al.Journal of Medicinal Chemistry|December 7, 2010
Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulatorsSimon E Ward, Mark Harries, Laura Aldegheri, et al.The Journal of Clinical Investigation|March 5, 2013
IgG4 subclass antibodies impair antitumor immunity in melanomaPanagiotis Karagiannis, Amy E Gilbert, Debra H Josephs, et al.Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.JAMA Oncology|February 16, 2023
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced MelanomaLaura A Bolte, Karla A Lee, Johannes R Björk, et al.Melanoma Research|July 31, 2015
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patientsSaif S Ahmad, Wendi Qian, Sarah Ellis, et al.Ebiomedicine|August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanomaNiccolò Rossi, Karla A Lee, Maria V Bermudez, et al.BMC Cancer|February 22, 2023
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanomaAlessia Visconti, Niccolò Rossi, Helena Deriš, et al.Pageof 7